1-anilino-8-naphthalenesulfonate has been researched along with Delusional Disorder in 2 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Besides the well-known adverse effects of clozapine, such as granulocytopenia, tiredness and hypersalivation, acute pancreatitis is known to be a very rare complication of the drug." | 8.80 | Asymptomatic pancreatitis associated with clozapine. ( Bergemann, N; Diebold, K; Ehrig, C; Mundt, C; von Einsiedel, R, 1999) |
| "Besides the well-known adverse effects of clozapine, such as granulocytopenia, tiredness and hypersalivation, acute pancreatitis is known to be a very rare complication of the drug." | 4.80 | Asymptomatic pancreatitis associated with clozapine. ( Bergemann, N; Diebold, K; Ehrig, C; Mundt, C; von Einsiedel, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ustohal, L | 1 |
| Mayerova, M | 1 |
| Valkova, B | 1 |
| Sedlakova, H | 1 |
| Kasparek, T | 1 |
| Bergemann, N | 1 |
| Ehrig, C | 1 |
| Diebold, K | 1 |
| Mundt, C | 1 |
| von Einsiedel, R | 1 |
1 review available for 1-anilino-8-naphthalenesulfonate and Delusional Disorder
| Article | Year |
|---|---|
Asymptomatic pancreatitis associated with clozapine.
Topics: Adult; Amylases; Antipsychotic Agents; Chronic Disease; Clozapine; Drug Monitoring; Hallucinations; | 1999 |
1 other study available for 1-anilino-8-naphthalenesulfonate and Delusional Disorder
| Article | Year |
|---|---|
Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment.
Topics: Adolescent; Amylases; Antipsychotic Agents; Benzodiazepines; Biomarkers; Female; Humans; Lipase; Ola | 2016 |